Purdue Pharma’s Hysingla ER might be the second high-dose hydrocodone formulation to be approved in ...
November 21, 2014
Welcome to your weekly digest of approaching regulatory and clinical readouts. By the end of the ...
If any confirmation were needed that the Royalty Pharma business model is working, look no further ...
November 20, 2014
November 17, 2014
November 19, 2014
November 12, 2014
October 17, 2014
October 16, 2014
Debt-funded biotechs under the spotlight
Allergan gets its happyish ending
Merck's minuscule benefit keeps cholesterol-lowering hypothesis alive
Receptos’s $360m haul signposts independent future for now
Medtech Half-Year Review 2014
Medtech Employment Stable Despite Harsh Environment
Big Pharma Becomes a Smaller Employer While Biotech Booms
Pharma & Biotech 2013 in Review
Medtech 2013 in Review
Terms & Conditions
Follow us on Twitter